Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan. Invest Ophthalmol Vis Sci. 2009 May; 50(5):2255-61.